Literature DB >> 29563328

Peroxisomal β-oxidation regulates whole body metabolism, inflammatory vigor, and pathogenesis of nonalcoholic fatty liver disease.

Maria E Moreno-Fernandez1,2, Daniel A Giles1,2,3, Traci E Stankiewicz1,2, Rachel Sheridan1,4, Rebekah Karns1,5, Monica Cappelletti1,2, Kristin Lampe1,2, Rajib Mukherjee1,2, Christian Sina6, Anthony Sallese1,7, James P Bridges1,7, Simon P Hogan1,8, Bruce J Aronow1,9, Kasper Hoebe1,2, Senad Divanovic1,2.   

Abstract

Nonalcoholic fatty liver disease (NAFLD), a metabolic predisposition for development of hepatocellular carcinoma (HCC), represents a disease spectrum ranging from steatosis to steatohepatitis to cirrhosis. Acox1, a rate-limiting enzyme in peroxisomal fatty acid β-oxidation, regulates metabolism, spontaneous hepatic steatosis, and hepatocellular damage over time. However, it is unknown whether Acox1 modulates inflammation relevant to NAFLD pathogenesis or if Acox1-associated metabolic and inflammatory derangements uncover and accelerate potential for NAFLD progression. Here, we show that mice with a point mutation in Acox1 (Acox1Lampe1) exhibited altered cellular metabolism, modified T cell polarization, and exacerbated immune cell inflammatory potential. Further, in context of a brief obesogenic diet stress, NAFLD progression associated with Acox1 mutation resulted in significantly accelerated and exacerbated hepatocellular damage via induction of profound histological changes in hepatocytes, hepatic inflammation, and robust upregulation of gene expression associated with HCC development. Collectively, these data demonstrate that β-oxidation links metabolism and immune responsiveness and that a better understanding of peroxisomal β-oxidation may allow for discovery of mechanisms central for NAFLD progression.

Entities:  

Keywords:  Cytokines; Fatty acid oxidation; Inflammation; Metabolism; Obesity

Mesh:

Substances:

Year:  2018        PMID: 29563328      PMCID: PMC5926941          DOI: 10.1172/jci.insight.93626

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  62 in total

1.  Sustained activation of PPARα by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice.

Authors:  Jiansheng Huang; Yuzhi Jia; Tao Fu; Navin Viswakarma; Liang Bai; M Sambasiva Rao; Yijun Zhu; Jayme Borensztajn; Janardan K Reddy
Journal:  FASEB J       Date:  2011-10-18       Impact factor: 5.191

Review 2.  From fat to inflammation.

Authors:  Christopher Paul Day
Journal:  Gastroenterology       Date:  2006-01       Impact factor: 22.682

3.  A guide to analysis of mouse energy metabolism.

Authors:  Matthias H Tschöp; John R Speakman; Jonathan R S Arch; Johan Auwerx; Jens C Brüning; Lawrence Chan; Robert H Eckel; Robert V Farese; Jose E Galgani; Catherine Hambly; Mark A Herman; Tamas L Horvath; Barbara B Kahn; Sara C Kozma; Eleftheria Maratos-Flier; Timo D Müller; Heike Münzberg; Paul T Pfluger; Leona Plum; Marc L Reitman; Kamal Rahmouni; Gerald I Shulman; George Thomas; C Ronald Kahn; Eric Ravussin
Journal:  Nat Methods       Date:  2011-12-28       Impact factor: 28.547

4.  Hepatic TLR4 signaling in obese NAFLD.

Authors:  Torfay Sharifnia; Joseph Antoun; Thomas G C Verriere; Giovanni Suarez; Julia Wattacheril; Keith T Wilson; Richard M Peek; Naji N Abumrad; Charles R Flynn
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-06-25       Impact factor: 4.052

Review 5.  TLR-dependent T cell activation in autoimmunity.

Authors:  Kingston H G Mills
Journal:  Nat Rev Immunol       Date:  2011-11-18       Impact factor: 53.106

Review 6.  Brown fat as a therapy for obesity and diabetes.

Authors:  Aaron M Cypess; C Ronald Kahn
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2010-04       Impact factor: 3.243

7.  Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for peroxisome proliferator-activated receptor alpha natural ligand metabolism.

Authors:  C Y Fan; J Pan; N Usuda; A V Yeldandi; M S Rao; J K Reddy
Journal:  J Biol Chem       Date:  1998-06-19       Impact factor: 5.157

8.  Pathophysiology of NASH: perspectives for a targeted treatment.

Authors:  Fabio Marra; Sophie Lotersztajn
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

Review 9.  The role of the lipogenic pathway in the development of hepatic steatosis.

Authors:  C Postic; J Girard
Journal:  Diabetes Metab       Date:  2008-12       Impact factor: 6.041

10.  Adipocyte death, adipose tissue remodeling, and obesity complications.

Authors:  Katherine J Strissel; Zlatina Stancheva; Hideaki Miyoshi; James W Perfield; Jason DeFuria; Zoe Jick; Andrew S Greenberg; Martin S Obin
Journal:  Diabetes       Date:  2007-09-11       Impact factor: 9.461

View more
  28 in total

1.  Acetyl-CoA Derived from Hepatic Peroxisomal β-Oxidation Inhibits Autophagy and Promotes Steatosis via mTORC1 Activation.

Authors:  Anyuan He; Xiaowen Chen; Min Tan; Yali Chen; Dongliang Lu; Xiangyu Zhang; John M Dean; Babak Razani; Irfan J Lodhi
Journal:  Mol Cell       Date:  2020-05-29       Impact factor: 17.970

2.  Loss- or Gain-of-Function Mutations in ACOX1 Cause Axonal Loss via Different Mechanisms.

Authors:  Hyung-Lok Chung; Michael F Wangler; Paul C Marcogliese; Juyeon Jo; Thomas A Ravenscroft; Zhongyuan Zuo; Lita Duraine; Sina Sadeghzadeh; David Li-Kroeger; Robert E Schmidt; Alan Pestronk; Jill A Rosenfeld; Lindsay Burrage; Mitchell J Herndon; Shan Chen; Amelle Shillington; Marissa Vawter-Lee; Robert Hopkin; Jackeline Rodriguez-Smith; Michael Henrickson; Brendan Lee; Ann B Moser; Richard O Jones; Paul Watkins; Taekyeong Yoo; Soe Mar; Murim Choi; Robert C Bucelli; Shinya Yamamoto; Hyun Kyoung Lee; Carlos E Prada; Jong-Hee Chae; Tiphanie P Vogel; Hugo J Bellen
Journal:  Neuron       Date:  2020-03-12       Impact factor: 17.173

Review 3.  Fructose and hepatic insulin resistance.

Authors:  Samir Softic; Kimber L Stanhope; Jeremie Boucher; Senad Divanovic; Miguel A Lanaspa; Richard J Johnson; C Ronald Kahn
Journal:  Crit Rev Clin Lab Sci       Date:  2020-01-14       Impact factor: 6.250

4.  PCB126 induced toxic actions on liver energy metabolism is mediated by AhR in rats.

Authors:  Nazmin Akter Eti; Susanne Flor; Khursheed Iqbal; Regan L Scott; Violet E Klenov; Katherine N Gibson-Corley; Michael J Soares; Gabriele Ludewig; Larry W Robertson
Journal:  Toxicology       Date:  2021-11-27       Impact factor: 4.571

5.  Evolution of altered tubular metabolism and mitochondrial function in sepsis-associated acute kidney injury.

Authors:  Ying Li; Noureddin Nourbakhsh; Hai Pham; Rick Tham; Jonathan E Zuckerman; Prabhleen Singh
Journal:  Am J Physiol Renal Physiol       Date:  2020-06-15

Review 6.  Inflammation and Immunity: From an Adipocyte's Perspective.

Authors:  Calvin C Chan; Michelle S M A Damen; Pablo C Alarcon; Joan Sanchez-Gurmaches; Senad Divanovic
Journal:  J Interferon Cytokine Res       Date:  2019-03-28       Impact factor: 2.607

7.  A BAFF/APRIL axis regulates obesogenic diet-driven weight gain.

Authors:  Calvin C Chan; Isaac T W Harley; Paul T Pfluger; Aurelien Trompette; Traci E Stankiewicz; Jessica L Allen; Maria E Moreno-Fernandez; Michelle S M A Damen; Jarren R Oates; Pablo C Alarcon; Jessica R Doll; Matthew J Flick; Leah M Flick; Joan Sanchez-Gurmaches; Rajib Mukherjee; Rebekah Karns; Michael Helmrath; Thomas H Inge; Stuart P Weisberg; Sünje J Pamp; David A Relman; Randy J Seeley; Matthias H Tschöp; Christopher L Karp; Senad Divanovic
Journal:  Nat Commun       Date:  2021-05-18       Impact factor: 14.919

8.  Cholesterol-binding translocator protein TSPO regulates steatosis and bile acid synthesis in nonalcoholic fatty liver disease.

Authors:  Yuchang Li; Liting Chen; Lu Li; Chantal Sottas; Stephanie K Petrillo; Anthoula Lazaris; Peter Metrakos; Hangyu Wu; Yuji Ishida; Takeshi Saito; Lucy Golden-Mason; Hugo R Rosen; Jeremy J Wolff; Cristina I Silvescu; Samuel Garza; Garett Cheung; Tiffany Huang; Jinjiang Fan; Martine Culty; Bangyan Stiles; Kinji Asahina; Vassilios Papadopoulos
Journal:  iScience       Date:  2021-05-01

9.  PKM2-dependent metabolic skewing of hepatic Th17 cells regulates pathogenesis of non-alcoholic fatty liver disease.

Authors:  Maria E Moreno-Fernandez; Daniel A Giles; Jarren R Oates; Calvin C Chan; Michelle S M A Damen; Jessica R Doll; Traci E Stankiewicz; Xiaoting Chen; Kashish Chetal; Rebekah Karns; Matthew T Weirauch; Lindsey Romick-Rosendale; Stavra A Xanthakos; Rachel Sheridan; Sara Szabo; Amy S Shah; Michael A Helmrath; Thomas H Inge; Hitesh Deshmukh; Nathan Salomonis; Senad Divanovic
Journal:  Cell Metab       Date:  2021-05-17       Impact factor: 31.373

10.  Aging mitigates the severity of obesity-associated metabolic sequelae in a gender independent manner.

Authors:  Maria E Moreno-Fernandez; Vishakha Sharma; Traci E Stankiewicz; Jarren R Oates; Jessica R Doll; Michelle S M A Damen; Maha A T A Almanan; Claire A Chougnet; David A Hildeman; Senad Divanovic
Journal:  Nutr Diabetes       Date:  2021-06-07       Impact factor: 5.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.